Björn Hackanson

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

Julia M. Wagner, Björn Hackanson, Michael Lübbert et al. · Clinical Epigenetics · 2010 · 394 citations · Full text

Histone Modifications, Chromatin, Cancer Therapy +9

Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia

Aparna Raval, Stephan M. Tanner, John C. Byrd et al. · Cell · 2007 · 366 citations · Full text

Hematological Malignancy, Tumor Biology, Chronic Lymphocytic Leukemia +9

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 283 citations · Full text

Cell Therapy, Flt3-itd-mutant Leukemia Cells, Immunology +7

Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1

Frank Rosenbauer, Bronwyn M. Owens, Li Yu et al. · Nature Genetics · 2005 · 240 citations

Cell Regulation, Cell Division, Key Regulatory Element +11

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Michael Lübbert, Björn Rüter, Rainer Claus et al. · Haematologica · 2011 · 230 citations · Full text